Breast Reconstruction in Austin, TX

Introduction

Written by Brian P. Kelley, MD — Dual Board-Certified Plastic & Hand Surgeon
‍Medically reviewed: May 4, 2026 · Last updated: May 4, 2026
Educational content. Not a substitute for individualized medical evaluation.

Breast reconstruction is one part of breast cancer care. The decisions involved — whether to reconstruct, when, with what technique, and what to expect over the long term — are personal and consequential. They are also frequently made during one of the harder weeks of a patient's life, in the days or weeks after a cancer diagnosis, when the volume of new information is already substantial.

I practice as a dual board-certified plastic and hand surgeon in Austin, Texas, with academic appointments at Dell Medical School at The University of Texas at Austin. My published work in breast reconstruction includes peer-reviewed systematic reviews on autologous and implant-based reconstruction in the setting of radiation therapy, a paper on tamoxifen and microvascular flap complications, and a 2024 senior-authored systematic review on the state of breast sensibility research.

This page is a parent overview of the three main reconstructive pathways — autologous (using your own tissue), implant-based, and oncoplastic — plus discussion of sensation, radiation, and timing. For deeper coverage of each pathway, see the cluster pages linked throughout.

How the Decision Is Approached

The right reconstructive plan depends on several factors: the cancer treatment plan (specifically whether radiation is required), the patient's body habitus and available donor tissue, the patient's medical history and tolerance for a longer or shorter operation, the breast size and goals for the reconstructed breast, and the patient's preference about timing.

Reconstruction can be performed immediately, at the time of mastectomy, so the patient wakes up with a reconstructed breast mound. It can also be performed delayed, weeks to years after mastectomy, particularly when radiation is required or when the patient wants time to consider options. Neither timing is universally correct. Immediate reconstruction offers psychological and aesthetic advantages in many patients. Delayed reconstruction is the right choice for some patients, including some patients undergoing post-mastectomy radiation and some who simply need more time.

There is also a distinction between mastectomy reconstruction and oncoplastic reconstruction. Mastectomy removes the breast entirely and is followed by either implant or autologous reconstruction. Oncoplastic reconstruction integrates plastic surgery with breast conservation (lumpectomy) — rearranging the remaining breast tissue at the time of cancer surgery to prevent deformity, often with a symmetry procedure on the contralateral side.

Autologous Reconstruction
(Using Your Own Tissues)

Autologous reconstruction rebuilds the breast using skin and fat from another part of the patient's body. The transferred tissue carries its own blood supply, which is microsurgically reconnected to recipient vessels in the chest under the operating microscope. Once revascularized, the tissue becomes a permanent, living part of the chest wall.

The advantages of autologous reconstruction follow from its biology. The breast is built from living tissue that responds to weight changes the way the patient's body does. There is no implant to maintain or replace over time. The result tolerates radiation better than an implant tolerates radiation — a meaningful consideration for patients who will require post-mastectomy radiation, where my co-authored systematic review in Annals of Surgical Oncology found that complication rates in autologous reconstruction were similar between pre- and post-radiation patients, while the parallel review of implant reconstruction found failure rates approaching 20% in the radiation setting.

The trade-offs are also real. Autologous reconstruction is a longer operation. The recovery is longer, particularly the first few weeks. A second surgical site (the donor area) requires its own healing. Not every patient is a candidate — donor tissue must be adequate, the recipient and donor vessels must be usable, and the patient must be medically able to tolerate a long microsurgical case.

DIEP Flap

The DIEP (deep inferior epigastric perforator) flap is the most commonly used autologous reconstruction. Skin and fat from the lower abdomen are transferred to the chest, with the perforator vessels supplying the tissue carefully dissected through but not removing the rectus abdominis muscle. This muscle-sparing approach distinguishes DIEP from the older TRAM flap, which sacrifices muscle and is associated with higher rates of abdominal weakness and hernia.

For appropriate candidates, DIEP delivers a breast that looks and behaves naturally, with the secondary effect of reshaping the abdomen as the donor tissue is taken. The operation is technically demanding, the recovery is measured in weeks rather than days, and the result is generally durable over decades. For deeper discussion of DIEP candidacy, surgical sequence, recovery timeline, and outcomes, see the [DIEP flap breast reconstruction page].

Alternative Donor Sites

Not every patient is a DIEP candidate. Some patients do not have enough lower abdominal tissue to produce the breast volume needed. Others have had prior abdominal surgery — certain hernia repairs, abdominoplasty — that compromises the perforator vessels. For these patients, alternative donor sites can be used.

The PAP (profunda artery perforator) flap uses tissue from the upper inner thigh. The TUG (transverse upper gracilis) flap uses tissue from a similar region. Both are muscle-sparing techniques. The SGAP and IGAP (superior and inferior gluteal artery perforator) flaps use tissue from the buttock region. The choice among alternative donor sites depends on body habitus, prior surgical history, and the volume of breast being reconstructed.

The microsurgical technique for all of these flaps is similar. The selection is matched to the patient's individual anatomy and goals.

Implant-Based Reconstruction

Implant-based reconstruction rebuilds the breast using a saline or silicone implant placed in the chest. There is no donor site, the operation is shorter, and immediate recovery is faster than autologous reconstruction. For patients who prefer to avoid a second surgical site, who do not have adequate donor tissue, or whose schedule does not accommodate a long microsurgical case, this is a reasonable and widely used option.

Modern implants are most commonly highly cohesive silicone gel devices (sometimes called "gummy bear" implants) that hold their shape and approximate the feel of native breast tissue. Saline implants remain available; they are inserted deflated, filled during surgery, and produce immediate visual deflation if they ever rupture — which simplifies surveillance but produces a firmer tactile profile.

In my practice, implants are typically placed pre-pectorally — above the pectoralis muscle — supported by an acellular dermal matrix (ADM) that creates a tissue plane resembling an internal hammock for the implant. Pre-pectoral placement avoids the animation deformity (visible flexing or movement of the implant with chest muscle activation) that can occur with subpectoral placement, and most patients report it as more natural.

For deeper discussion of implant types, the FDA history and surveillance considerations (including BIA-ALCL and Breast Implant Illness), and outcomes, see the [implant-based breast reconstruction page].

Direct-to-Implant

Direct-to-implant reconstruction places the permanent implant in the same operation as the mastectomy. Patients wake up with reconstruction complete, avoiding a separate exchange surgery later. This is most often appropriate after nipple-sparing mastectomy when the breast surgeon has preserved healthy, well-perfused skin flaps. Fluorescence imaging is used during the operation to confirm flap viability before committing to the implant.

Direct-to-implant has some constraints. The reconstructed breast typically matches or slightly reduces the pre-operative size; substantial increases in size are not generally possible in a single stage. If the skin flap quality is marginal, the safer choice is to pivot to a staged tissue expander approach rather than force the implant into a compromised pocket.

Tissue Expander Reconstruction

Tissue expander reconstruction is the more traditional staged approach. At the time of mastectomy, an inflatable expander is placed in the breast pocket. Over weeks, the expander is gradually filled with saline through a subcutaneous port to stretch the skin envelope. Once expansion is complete, a second outpatient operation replaces the expander with the permanent implant.

This staged approach is essential when post-mastectomy radiation is required. The expander holds the space during radiation, the radiation completes, and the permanent implant is then placed into healed tissue. My co-authored systematic review in Annals of Surgical Oncology on implant-based reconstruction with pre- or post-reconstruction radiotherapy supported this kind of staged approach as a way to manage the substantial complication rates that radiation introduces to implant reconstruction.

Oncoplastic Reconstruction

Oncoplastic reconstruction integrates plastic surgical principles with breast conservation surgery (lumpectomy) rather than mastectomy. When a lumpectomy will remove enough breast tissue to produce a visible contour deformity, oncoplastic techniques rearrange the remaining breast tissue at the time of cancer surgery to maintain shape and avoid deformity. A contralateral symmetry procedure — typically a lift, reduction, or augmentation on the unaffected side — is often performed at the same time.

For deeper discussion of oncoplastic indications, technique categories, and the role of fat grafting in correcting post-radiation deformities, see the [oncoplastic breast reconstruction page].

Sensation and Reinnervation After Mastectomy

One of the long-term consequences of mastectomy that patients are often underprepared for is the loss of breast sensation. A standard mastectomy divides the small cutaneous nerves that supply the breast skin and nipple-areolar complex. Reconstruction with implants does not restore innervation. Reconstruction with a flap brings new vascularized tissue to the chest, but unless that tissue is specifically reconnected to recipient nerves, it remains insensate.

Several techniques attempt to restore sensation by reconnecting nerves at the time of reconstruction. Sensate flap techniques identify a sensory nerve in the donor flap and coapt it to a recipient sensory nerve at the chest wall. When the gap between donor and recipient nerves is too long for direct coaptation, an autologous nerve graft or processed nerve allograft can bridge it.

The honest framing matters here. As senior author on the 2024 JPRAS systematic review "Toward Breast Reinnervation — What is Our Endpoint," I helped examine the published literature on breast sensibility and reinnervation. The review's central finding is that the field has not yet established normative measurements for breast sensation in healthy controls, which means the question of how much of normal sensation any reinnervation technique restores cannot yet be answered with precision. Patients who undergo reinnervation procedures are more likely than patients undergoing standard reconstruction to recover some sensation, but normal pre-mastectomy sensation is essentially never restored, and the durability of recovered sensation over many years is not yet well documented.

For deeper discussion of breast sensation, post-mastectomy pain, and the realistic limits of current surgery, see the [breast sensation after mastectomy blog post].

A Brief Note on Lymphedema

Patients who undergo axillary lymph node dissection — particularly when combined with regional radiation — face an elevated risk of developing lymphedema, a chronic swelling of the upper extremity from disrupted lymphatic drainage. Lymphovenous bypass (LVB) is a microsurgical technique that attempts to address this either prophylactically at the time of axillary node dissection or therapeutically after lymphedema has developed. The evidence base supports continued use of these techniques in selected patients but is not yet definitive. For deeper discussion, see the [lymphovenous bypass for breast cancer lymphedema blog post].

Outcomes

Breast reconstruction outcomes are evaluated across several dimensions. Aesthetic outcomes — symmetry, shape, scar appearance — depend on the technique chosen, the original anatomy, and whether radiation is required. Functional outcomes include sensation (typically reduced regardless of technique), nipple-areolar appearance, and absence of chronic pain. Durability outcomes vary: autologous reconstructions are generally lifelong, while implant reconstructions require some long-term surveillance and may require revision over time.

The honest framing is that reconstruction is restoration, not replacement. Even an excellent reconstruction does not return the breast to its pre-cancer state. Sensation is typically reduced. Scars are present. Some patients require revision surgery for refinement. Most patients accept these trade-offs readily because the alternative is no reconstruction, and the realistic expectations are part of the consultation before surgery.

Risks

Risks of breast reconstruction depend on the technique. Common across all techniques: bleeding, infection, hematoma, seroma, wound healing problems, and unsatisfactory aesthetic result. Autologous reconstruction adds the specific risks of microvascular surgery: partial or total flap loss, fat necrosis, and donor site complications. Implant reconstruction adds the specific risks of foreign material: capsular contracture, implant malposition, rupture, and the rare risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) — almost exclusively associated with textured implants, which I do not use in my practice.

Patients who smoke, who have uncontrolled diabetes, or who have had prior radiation face elevated risk profiles in any reconstructive approach. Honest counseling addresses these factors before surgery.

‍

Closing Disclaimer

This article is educational and does not establish a doctor-patient relationship. It does not replace individualized consultation, examination, or review of personal medical history. Patients with sensory changes or pain after mastectomy are encouraged to discuss their specific situation with their oncology team and, when appropriate, with a plastic surgeon experienced in nerve and breast surgery.

‍

Related Topics

• DIEP flap breast reconstruction
• Implant-based breast reconstruction
• Oncoplastic breast reconstruction
• Breast Sensation After Breast Reconstruction
• Lymphovenous bypass for breast cancer lymphedema
• Peripheral nerve surgery, RPNI, and TMR
• TMR and RPNI for nerve pain and amputations
• Revising a Breast Reconstruction Done in the Past

‍

Written by Brian P. Kelley, MD — Dual Board-Certified Plastic & Hand Surgeon
‍Medically reviewed: May 4, 2026 · Last updated: May 4, 2026
Educational content. Not a substitute for individualized medical evaluation.

‍

Medical References

1. Kelley BP, Ahmed R, Kidwell KM, Kozlow JH, Chung KC, Momoh AO. A systematic review of morbidity associated with autologous breast reconstruction before and after exposure to radiotherapy: are current practices ideal? Annals of Surgical Oncology. 2014;21(5):1732–1738. PMID: 24473643.
2. Momoh AO, Ahmed R, Kelley BP, Aliu O, Kidwell KM, Kozlow JH, Chung KC. A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Annals of Surgical Oncology. 2014;21(1):118–124. PMID: 24081801.
3. Kelley BP, Valero V, Yi M, Kronowitz SJ. Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plastic and Reconstructive Surgery. 2012;129(2):305–314. PMID: 21987043.
4. Schafer HA, Leathers KO, Mumford KC, Ilangovan S, Vetter IL, Henry SL, Kelley BP, Torres-Guzman RA, Egeland BM. "Toward Breast Reinnervation — What is our Endpoint": A Systematic Review of Normal Breast Sensibility. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2024;91:383–398. PMID: 38461623.
5. American Society of Plastic Surgeons — breast reconstruction resources: https://www.plasticsurgery.org/.